Cancers Related to Immunodeficiencies: Update and Perspectives.
Cancers Related to Immunodeficiencies: Update and Perspectives.
复制标题
DOI:
10.3389/fimmu.2016.00365
复制
发表时间:
2016
影响因子:
7.3
通讯作者:
Adcock IM
中科院分区:
文献类型:
--
作者:
Mortaz E;Tabarsi P;Mansouri D;Khosravi A;Garssen J;Velayati A;Adcock IM
The life span of patients with primary and secondary immunodeficiency is increasing due to recent improvements in therapeutic strategies. While the incidence of primary immunodeficiencies (PIDs) is 1:10,000 births, that of secondary immunodeficiencies are more common and are associated with posttransplantation immune dysfunction, with immunosuppressive medication for human immunodeficiency virus or with human T-cell lymphotropic virus infection. After infection, malignancy is the most prevalent cause of death in both children and adults with (PIDs). PIDs more often associated with cancer include common variable immunodeficiency (CVID), Wiskott–Aldrich syndrome, ataxia-telangiectasia, and severe combined immunodeficiency. This suggests that a protective immune response against both infectious non-self-(pathogens) and malignant self-challenges (cancer) exists. The increased incidence of cancer has been attributed to defective elimination of altered or “transformed” cells and/or defective immunity towards cancer cells. The concept of aberrant immune surveillance occurring in PIDs is supported by evidence in mice and from patients undergoing immunosuppression after transplantation. Here, we discuss the importance of PID defects in the development of malignancies and the current limitations associated with molecular pathogenesis of these diseases and emphasize the need for further knowledge of how specific mutations can modulate the immune system to alter immunosurveillance and thereby play a key role in the etiology of malignancies in PID patients.
登录
查看更多内容
影响因子:
7.3
作者:
Al-Herz W;Bousfiha A;Casanova JL;Chatila T;Conley ME;Cunningham-Rundles C;Etzioni A;Franco JL;Gaspar HB;Holland SM;Klein C;Nonoyama S;Ochs HD;Oksenhendler E;Picard C;Puck JM;Sullivan K;Tang ML
通讯作者:
Tang ML
影响因子:
14.9
作者:
Bresnick EH;Katsumura KR;Lee HY;Johnson KD;Perkins AS
通讯作者:
Perkins AS
影响因子:
56.9
作者:
Bauer, S;Groh, V;Spies, T
通讯作者:
Spies, T
影响因子:
13.6
作者:
Brandt, Daniel;Gershwin, M. Eric
通讯作者:
Gershwin, M. Eric
影响因子:
2.6
作者:
Aghamohammadi, A;Parvaneh, N;Webster, D
通讯作者:
Webster, D